| Dr Lawrence J Robinson Jr, MD | |
|
1523 W Avenue J, Suite # 7, Lancaster, CA 93534-2819 | |
| (661) 945-2221 | |
| (661) 945-0831 |
| Full Name | Dr Lawrence J Robinson Jr |
|---|---|
| Gender | Male |
| Speciality | Allergy & Immunology - Allergy |
| Location | 1523 W Avenue J, Lancaster, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023037652 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207KA0200X | Allergy & Immunology - Allergy | C35069 (California) | Primary |
| 208000000X | Pediatrics | C35069 (California) | Secondary |
| Entity Name | Av Pediatrics Medical Associates. Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275592867 PECOS PAC ID: 8628052404 Enrollment ID: O20040617001187 |
News Archive
Researchers have identified several modifiable risk factors significantly associated with wound complications after obstetric anal sphincter injuries.
The University of Texas MD Anderson Cancer Center has received more than $22 million in research grants this week from the Cancer Prevention and Research Institute of Texas. Approximately half of the funds awarded for Individual Investigator Research Awards went to MD Anderson faculty as well as 40 percent of total IIRA awards that include those for children's and adolescent cancer and early detection and prevention.
Neurologix, Inc., a biotechnology company engaged in the development of innovative therapies for the brain and central nervous system, today announced that it has hired MTS Health Partners, L.P. as strategic advisor to complement and augment the company's ongoing business development activities.
The Foundation for Innovative New Diagnostics announced today the launch of a new schistosomiasis programme within its neglected tropical diseases portfolio.
› Verified 2 days ago
| Entity Name | Florence Western Medical Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154347797 PECOS PAC ID: 1850485962 Enrollment ID: O20070920000311 |
News Archive
Researchers have identified several modifiable risk factors significantly associated with wound complications after obstetric anal sphincter injuries.
The University of Texas MD Anderson Cancer Center has received more than $22 million in research grants this week from the Cancer Prevention and Research Institute of Texas. Approximately half of the funds awarded for Individual Investigator Research Awards went to MD Anderson faculty as well as 40 percent of total IIRA awards that include those for children's and adolescent cancer and early detection and prevention.
Neurologix, Inc., a biotechnology company engaged in the development of innovative therapies for the brain and central nervous system, today announced that it has hired MTS Health Partners, L.P. as strategic advisor to complement and augment the company's ongoing business development activities.
The Foundation for Innovative New Diagnostics announced today the launch of a new schistosomiasis programme within its neglected tropical diseases portfolio.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lawrence J Robinson Jr, MD 1523 W Avenue J, Suite # 7, Lancaster, CA 93534-2819 Ph: (661) 945-2221 | Dr Lawrence J Robinson Jr, MD 1523 W Avenue J, Suite # 7, Lancaster, CA 93534-2819 Ph: (661) 945-2221 |
News Archive
Researchers have identified several modifiable risk factors significantly associated with wound complications after obstetric anal sphincter injuries.
The University of Texas MD Anderson Cancer Center has received more than $22 million in research grants this week from the Cancer Prevention and Research Institute of Texas. Approximately half of the funds awarded for Individual Investigator Research Awards went to MD Anderson faculty as well as 40 percent of total IIRA awards that include those for children's and adolescent cancer and early detection and prevention.
Neurologix, Inc., a biotechnology company engaged in the development of innovative therapies for the brain and central nervous system, today announced that it has hired MTS Health Partners, L.P. as strategic advisor to complement and augment the company's ongoing business development activities.
The Foundation for Innovative New Diagnostics announced today the launch of a new schistosomiasis programme within its neglected tropical diseases portfolio.
› Verified 2 days ago
Saad Matti Bakhaya, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 1629 West Avenue J, Suite 116, Lancaster, CA 93534 Phone: 661-945-1511 Fax: 661-945-5539 |